Clinical implications of novel aspects of biliary pathophysiology

Digestive and Liver Disease

Volumn 42, Issue 4, 2010, Pages 238-244

  Marzioni, Marco ^a   Saccomanno, Stefania ^a   Candelaresi, Cinzia ^a   Rychlicki, Chiara ^a   Agostinelli, Laura ^a   Trozzi, Luciano ^a   De Minicis, Samuele ^a   Benedetti, Antonio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cholangiocarcinoma; Cholangiocyte; Cholangiopathies; Neuroendocrine; Proliferation

Indexed keywords

BILE ACID; ESTROGEN; GLUCAGON LIKE PEPTIDE 1; GROWTH HORMONE; OPIATE PEPTIDE; SEROTONIN; TAUROCHOLIC ACID; TAUROLITHOCHOLIC ACID; URSODEOXYCHOLIC ACID; VASCULOTROPIN;

AUTOCRINE EFFECT; AUTONOMIC INNERVATION; BILE DUCT CARCINOMA; BILE DUCT DISEASE; CARCINOGENESIS; CELL PROLIFERATION; CHOLANGIOCYTE; CYTOKINE RELEASE; GENETIC HETEROGENEITY; HUMAN; INFLAMMATION; LIVER CELL; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

AUTONOMIC NERVOUS SYSTEM; BILE ACIDS AND SALTS; BILE DUCT DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS; CHOLESTASIS; CYTOKINES; EPITHELIAL CELLS; HORMONES; HUMANS; INFLAMMATION; NEUROPEPTIDES;

EID: 77649192568     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.01.005     Document Type: Short Survey

References (98)

1. Alpini G., McGill J.M., and LaRusso N.F. The pathobiology of biliary epithelia. Hepatology 35 (2002) 1256-1268
2. Marzioni M., Glaser S.S., Francis H., et al. Functional heterogeneity of cholangiocytes. Semin Liver Dis 22 (2002) 227-240
3. Desmet V.J. Vanishing bile duct disorders. Prog Liver Dis 10 (1992) 89-121
4. Lazaridis K.N., Strazzabosco M., and LaRusso N.F. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127 (2004) 1565-1577
5. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1991-2000 (2001), Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD
6. Blechacz B., and Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48 (2008) 308-321
7. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
8. Alvaro D., Mancino M.G., Glaser S., et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132 (2007) 415-431
9. Vierling J.M. Biliary victories: studies of isolated biliary epithelial cells. J Lab Clin Med 113 (1989) 663-664
10. Alpini G., Glaser S., Robertson W., et al. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol 272 (1997) G1064-G1074
11. Alpini G., Glaser S.S., Ueno Y., et al. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol 274 (1998) G767-G775
12. Alpini G., Roberts S., Kuntz S.M., et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110 (1996) 1636-1643
13. Alpini G., Ulrich C., Roberts S., et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 272 (1997) G289-G297
14. Benedetti A., Bassotti C., Rapino K., et al. A morphometric study of the epithelium lining the rat intrahepatic biliary tree. J Hepatol 24 (1996) 335-342
15. Alpini G., Ulrich II C.D., Phillips J.O., et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 266 (1994) G922-G928
16. Glaser S.S., Rodgers R.E., Phinizy J.L., et al. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol 273 (1997) G1061-G1070
17. - exchange in cholangiocytes. Am J Physiol 273 (1997) G303-G313
18. Fitz J.G., Basavappa S., McGill J., et al. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91 (1993) 319-328
19. Alvaro D., Alpini G., Jezequel A.M., et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest 100 (1997) 1349-1362
20. Alpini G., Lenzi R., Sarkozi L., et al. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 81 (1988) 569-578
21. +-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology 113 (1997) 1734-1740
22. LeSage G., Glaser S., Marucci L., et al. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from bile duct ligated rat liver. Am J Physiol 276 (1999) G1289-G1301
23. Lazaridis K.N., Pham L., Tietz P., et al. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 100 (1997) 2714-2721
24. Scheffer G.L., Kool M., de Haas M., et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82 (2002) 193-201
25. Lazaridis K.N., Tietz P., Wu T., et al. Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proc Natl Acad Sci USA 97 (2000) 11092-11097
26. Ballatori N., Christian W.V., Lee J.Y., et al. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42 (2005) 1270-1279
27. Alpini G., Ueno Y., Glaser S., et al. Bile acid feeding stimulates proliferative activity of both small and large cholangiocytes through activation and membrane translocation of protein kinase C alpha. Hepatology 34 (2001) 868-876
28. Alpini G., Ueno Y., Glaser S.S., et al. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34 (2001) 868-876
29. Alpini G., Glaser S., Ueno Y., et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116 (1999) 179-186
30. Alpini G., Glaser S., Robertson W., et al. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol 273 (1997) G518-G529
31. Alpini G., Baiocchi L., Glaser S., et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology 35 (2002) 1041-1052
32. Marzioni M., Ueno Y., Glaser S., et al. Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver. Liver Int 27 (2007) 558-568
33. Marzioni M., LeSage G., Glaser S., et al. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats. Am J Physiol 284 (2003) G837-G852
34. 4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 284 (2003) G290-G301
35. 2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. Am J Pathol 168 (2006) 398-409
36. Alpini G., Glaser S., Alvaro D., et al. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology 123 (2002) 1226-1237
37. 2+ signaling in rat bile duct epithelia. Am J Physiol 271 (1996) G86-G96
38. LeSage G., Alvaro D., Benedetti A., et al. Cholinergic system modulates growth, apoptosis and secretion of cholangiocytes from bile duct ligated rats. Gastroenterology 117 (1999) 191-199
39. Iwai M., and Shimazu T. Alteration in sympathetic nerve activity during liver regeneration in rats after partial hepatectomy. J Auton Nerv Syst 41 (1992) 209-214
40. LeSage G.D., Alvaro D., Glaser S., et al. Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP. Hepatology 40 (2004) 1116-1127
41. Francis H., LeSage G., Demorrow S., et al. The {alpha}2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. Am J Physiol Cell Physiol 293 (2007) C1252-C1262
42. Glaser S., Alvaro D., Francis H., et al. Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol 290 (2006) G813-G826
43. Fava G., Marzioni M., Francis H., et al. Novel interaction of bile acid and neural signaling in the regulation of cholangiocyte function. Hepatol Res 37 Suppl. 3 (2007) S420-S429
44. Alvaro D., Alpini G., Onori P., et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 123 (2002) 336-344
45. Alvaro D., Alpini G., Onori P., et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119 (2000) 1681-1691
46. Marzioni M., Glaser S., Francis H., et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 128 (2005) 121-137
47. Marzioni M., Svegliati Baroni G., Alpini G., et al. Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 46 (2007) 583-586
48. Bergasa N.V., Liau S., Homel P., et al. Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis. Liver 22 (2002) 107-113
49. Bergasa N.V., Rothman R.B., Vergalla J., et al. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 15 (1992) 220-224
50. Bergasa N.V., Vergalla J., Swain M.G., et al. Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis. Liver 16 (1996) 298-302
51. Swain M.G., Rothman R.B., Xu H., et al. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 103 (1992) 630-635
52. Bergasa N.V., Sabol S.L., Young III W.S., et al. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 268 (1995) G346-G354
53. Marzioni M., Alpini G., Saccomanno S., et al. Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 130 (2006) 1831-1847
54. Alvaro D., Metalli V.D., Alpini G., et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 43 (2005) 875-883
55. Gaudio E., Barbaro B., Alvaro D., et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130 (2006) 1270-1282
56. Gaudio E., Barbaro B., Alvaro D., et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 291 (2006) G307-G317
57. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 (2002) 531-544
58. Marzioni M., Alpini G., Saccomanno S., et al. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. Gastroenterology 133 (2007) 244-255
59. Marzioni M., Alpini G., Saccomanno S., et al. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis. Gut 58 (2009) 990-997
60. Bulotta A., Hui H., Anastasi E., et al. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. J Mol Endocrinol 29 (2002) 347-360
61. Zhou J., Wang X., Pineyro M.A., et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48 (1999) 2358-2366
62. Nagaya M., Kubota S., Isogai A., et al. Ductular cell proliferation in islet cell neogenesis induced by incomplete ligation of the pancreatic duct in dogs. Surg Today 34 (2004) 586-592
63. Yang L., Li S., Hatch H., et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 99 (2002) 8078-8083
64. Hanada S., Harada M., Koga H., et al. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 23 (2003) 3-11
65. Spirli C., Fabris L., Duner E., et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology 124 (2003) 737-753
66. Spirli C., Nathanson M.H., Fiorotto R., et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 121 (2001) 156-169
67. Morland C.M., Fear J., McNab G., et al. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 109 (1997) 372-382
68. Heydtmann M., Lalor P.F., Eksteen J.A., et al. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 174 (2005) 1055-1062
69. Eksteen B., Miles A., Curbishley S.M., et al. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol 177 (2006) 593-603
70. Xu B., Broome U., Ericzon B.G., et al. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 51 (2002) 120-127
71. Karrar A., Broome U., Sodergren T., et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132 (2007) 1504-1514
72. Bioulac-Sage P., Lafon M.E., Saric J., et al. Nerves and perisinusoidal cells in human liver. J Hepatol 10 (1990) 105-112
73. Salas J.T., Banales J.M., Sarvide S., et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 134 (2008) 1482-1493
74. Poupon R., Ping C., Chretien Y., et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 49 (2008) 1038-1045
75. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51 (2009) 237-267
76. Fickert P., Zollner G., Fuchsbichler A., et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123 (2002) 1238-1251
77. Fickert P., Fuchsbichler A., Wagner M., et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127 (2004) 261-274
78. Fickert P., Wagner M., Marschall H.U., et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130 (2006) 465-481
79. Halilbasic E., Fiorotto R., Fickert P., et al. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology 49 (2009) 1972-1981
80. Buis C.I., Geuken E., Visser D.S., et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol 50 (2009) 69-79
81. Alvaro D., Invernizzi P., Onori P., et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41 (2004) 905-912
82. Jones E.A., and Bergasa N.V. The pruritus of cholestasis. Hepatology 29 (1999) 1003-1006
83. Thornton J.R., and Losowsky M.S. Opioid peptides and primary biliary cirrhosis. Br Med J 297 (1988) 1501-1504
84. Bergasa N.V., Thomas D.A., Vergalla J., et al. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. Life Sci 53 (1993) 1253-1257
85. Jones E.A., Neuberger J., and Bergasa N.V. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. Q J Med 95 (2002) 547-552
86. Mayo M.J., Handem I., Saldana S., et al. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 45 (2007) 666-674
87. Marzioni M., Invernizzi P., Candelaresi C., et al. Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. Dig Liver Dis 41 (2009) 523-533
88. Alpini G., Invernizzi P., Gaudio E., et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 68 (2008) 9184-9193
89. Washington K., Clavien P.A., and Killenberg P. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis. Hum Pathol 28 (1997) 791-795
90. Beaussier M., Wendum D., Schiffer E., et al. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87 (2007) 292-303
91. Alvaro D., Barbaro B., Franchitto A., et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 169 (2006) 877-888
92. Mancino A., Mancino M.G., Glaser S.S., et al. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig Liver Dis 41 (2009) 156-163
93. Alvaro D., Macarri G., Mancino M.G., et al. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med 147 (2007) 451-459
94. Amori R.E., Lau J., and Pittas A.G. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. J Am Med Assoc 298 (2007) 194-206
95. Beuers U., and Goke B. GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?. Gut 58 (2009) 902-903
96. Sasatomi K., Noguchi K., Sakisaka S., et al. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 29 (1998) 409-416
97. Fava G., Alpini G., Rychlicki C., et al. Leptin enhances cholangiocarcinoma cell growth. Cancer Res 68 (2008) 6752-6761
98. Fickert P., Stoger U., Fuchsbichler A., et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171 (2007) 525-536